Literatur
-
1
Assaraf Y G, Golenser J, Spira D T, Bachrach U.
Polyamine
levels and the activity of their biosynthetic enzymes in human erythrocytes
infected with the malarial parasite, Plasmodium falciparum.
Biochemical Journal.
1984;
222
815-819
-
2
Beeson J G.
New
agents to combat malaria.
Nature Medicine.
2001;
7
149-150
-
3
Brockman A. et al .
Plasmodium falciparum antimalarial drug
susceptibility on the north-western border of Thailand during five
years of extensive use of artesunate-mefloquine.
Trans
Roy Soc Tropical Med Hygiene.
2000;
94
537-544
-
4
Butcher G A, Mendoza J, Sinden R E.
Inhibition
of the mosquito transmission of Plasmodium berghei by Malarone (atovaquon-proguanil).
Ann
Tropical Med Parasitol.
2000;
94
429-436
-
5
Caraglia M, Tagliaferri P, Budillon A.
Post-translational
modifications of eukaryotic initiation factor (eIF5A) as a new target
for anticancer therapy.
Adv Nutrition Cancer.
1999;
2
187-197
-
6
Chen Z P, Yan Y P, Ding Q J. et al .
Effect of inhibitors of
deoxyhypusine synthase on the differentiation of mouse neuroblastoma
and erythroleukemia cells.
Cancer Letters.
1996;
105
233-239
-
7
Fowler R E, Sinden R E, Pudney M.
Inhibitory
activity of the anti-malarial atovaquone (566C80) against ookinetes,
oocysts and sporozoites of Plasmodium berghei.
J Parasitol.
1995;
81
452-458
-
8
Hana K, Kamekura M, Onishi H, Akazawa T, Matsuzaki S.
Polyamines in
photosynthetic eubacteria and extreme-halophilic archaebacteria.
J
Biochemistry.
1985;
97
1595-1601
-
9
Ivens A C, Lewis S M, Bagherzadeh A.
A
physical map of the Leishmania major Friedlin genome.
Genome
Research.
1998;
8
135-148
-
10
Jomaa H, Wiesner J, Sanderbrand S. et al .
Inhibitors of the mevalonate pathway of
isoprenoid biosynthesis as antimalarial drugs.
Science.
1999;
285
1573-1575
-
11
Kaiser A, Gottwald A, Wiersch C, Lindenthal B, Maier W, Seitz H M.
Effect of drugs
inhibiting spermidine biosynthesis and metabolism on the in vitro
development of Plasmodium falciparum.
Parasitology Research.
2001;
87
963-972
-
12
Kaiser A.
Biotechnologische
Malariaforschung.
Dtsch Apotheker Z.
2000;
11
1164-1168
-
13
Köhler S.
A
plastid of probable green algal-origin in apicomplexan parasites.
Science.
1997;
275
1485-1488
-
14
Krause T, Lüersen K, Wrenger C, Gilberger T W, Müller S, Walter R D.
The
ornithine decarboxylase domain of the bifunctional ornithine decarboxylase/S-adenosylmethionine
decarboxylase of P. falciparum: Recombinant expression and catalytic
properties of two different constructs.
Biochem J.
2000;
352
287-292
-
15
Lamparter S, Schoner K, Moll R, Memel H D, Maisch B.
Foudroyanter Verlauf
einer Malaria tropica.
Dtsch Med Wochenschr.
2001;
126
76-78
-
16
Müller S, Da’dara A, Lüersen K. et al .
In the human malaria parasite
P. falciparum polyamines are synthesized by a bifunctional ornithine decarboxylase,
S-adenosylmethionine decarboxylase.
J Biol Chemistry.
2000;
275
8097-8102
-
17
Müller S, Coombs G H, Walter R D.
Targeting polyamines of parasitic protozoa
in chemotherapy.
Trends Parasitol.
2001;
15
242-243
-
18
Pandey A V, Tekwani B L, Singh R L, Chauhan V S.
Artemisinin,
an endoperoxide antimalarial, disrupts the hemoglobin catabolism
and heme detoxification systems in malarial parasite.
J
Biol Chemistry.
1999;
274
19 383-19 388
-
19
Ridley R G.
Medical
need, scientific opportunity and the drive for antimalarial drugs.
Nature.
2002;
686-692
-
20 Risk A F. The
pyrrolizidine alkaloids: plant sources and properties, 1 - 89. CRC
Press, BocuRaton in: Rizk (Herausgeber) Naturally
occuring pyrrolizidine alkaloids 1991
-
21
Report WHO .
Reducing
Mortality from major killers of children.
WHO.
2002;
178
1-7
-
22
Report WHO .
Roll
Back Malaria-Progress Report I and Report II.
WHO Weekly
epidemiological record.
2001;
76
77-92
-
23
Schwake L, Junghanss T, Weimann J, Stremmel W.
Importierte Malaria
tropica nach Keniaaufenthalt. Schwerwiegende Folgen von unterlassener
Chemoprophylaxe und verspäteter Diagnose.
Dtsch
Med Wochenschr.
2001;
126
1428
-
24
Stephenson J.
Sequencing
of the malaria genome opens door to vaccines and new drugs.
JAMA.
2002;
287
1-5
-
25
Strong W B, Nelson R G.
Preliminary
profile of the Cryptosporidium parvum genome.
Molec Biochem
Parasitol.
2000;
107
1-32
-
26
Surolia N, Surolia A.
Triclosan offers protection
against blood stages of malaria by inhibiting enoyl-ACP reductase
of Plasmodium falciparum.
Nature Med.
2001;
7
167-172
-
27
Takechi M. et al .
Therapeutic effiacy of sulphadoxine-pyrimethamine and
susceptibility in vitro of P. falciparum isolates to sulphadoxine/pyrimethamine
and other antimalarial in Malawian children.
Tropical
Med Intern Health.
2001;
6
429-434
-
28
Tholl D, Ober D, Martin W, Kellermann J, Hartmann T.
Purification, molecular
cloning and expression in Escherichia coli of homospermidine synthase
from Rhodopseudomonas viridis.
Europ J Biochem.
1996;
240
373-379
-
29
Wolff E C, Park M H, Folk J E.
Cleavage of spermidine as the first step
in deoxyhypusine synthesis.
J Biol Chemistry.
1989;
265
4793-4799
-
30
Wright P S, Byers T L, Cross-Doersen D E, Mc Cann P P, Bitonti A J.
Irreversible
inhibition of S-adenosylmethionine decarboxylase in Plasmodium falciparum-infected
erythrocytes: Growth inhibition in vitro.
Biochem Pharmacol.
1990;
41
1713-1718
Dr. Annette Kaiser
Telefon: 0228/2876838
Fax: 0228/2874330
eMail: akaiser@parasit.meb.uni-bonn.de
